Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Dyslipidemias"" wg kryterium: Temat


Tytuł :
Cost-Effectiveness of Using LDL-Direct Versus Lipid-Panel as Part of the Inpatient Stroke Workup.
Autorzy :
Lane R; UC San Diego Hospital, 200 West Arbor Dr., San Diego, CA 92103, United States. Electronic address: .
Agrawal K; UC San Diego Hospital, 200 West Arbor Dr., San Diego, CA 92103, United States.
Modir R; UC San Diego Hospital, 200 West Arbor Dr., San Diego, CA 92103, United States; Stroke Center - University of California, San Diego, United States.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Feb; Vol. 30 (2), pp. 105417. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Journal Article
MeSH Terms :
Hospital Costs*
Blood Chemical Analysis/*economics
Dyslipidemias/*diagnosis
Dyslipidemias/*economics
Ischemic Attack, Transient/*diagnosis
Ischemic Attack, Transient/*economics
Ischemic Stroke/*diagnosis
Lipoproteins, LDL/*blood
Biomarkers/blood ; California ; Cost Savings ; Cost-Benefit Analysis ; Dyslipidemias/blood ; Dyslipidemias/drug therapy ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Inpatients ; Ischemic Attack, Transient/blood ; Ischemic Attack, Transient/drug therapy ; Ischemic Stroke/blood ; Ischemic Stroke/drug therapy ; Ischemic Stroke/economics ; Predictive Value of Tests ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The effect of probiotic fermented milk products on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials.
Autorzy :
Ziaei R; Student Research Committee, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Ghavami A; Student Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Khalesi S; Appleton Institute & School of Health Medical and Applied Sciences, CQUniversity, Brisbane, Australia.
Ghiasvand R; Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: .
Mokari Yamchi A; Student Research Committee, Department of Community Nutrition, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Apr 09; Vol. 31 (4), pp. 997-1015. Date of Electronic Publication: 2020 Dec 31.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Cholesterol/*blood
Cultured Milk Products/*microbiology
Dyslipidemias/*diet therapy
Probiotics/*therapeutic use
Adult ; Aged ; Biomarkers/blood ; Cholesterol, LDL/blood ; Down-Regulation ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/microbiology ; Female ; Humans ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
LDL-C Levels Below 55 mg/dl and Risk of Hemorrhagic Stroke: A Meta-Analysis.
Autorzy :
Masson W; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina; Cardiology Department. Hospital Italiano de Buenos Aires. Tte. Gral. Juan Domingo Perón 4190 (C1199ABB), Buenos Aires, Argentina. Electronic address: .
Lobo M; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina; Cardiology Department. Hospital Militar Campo de Mayo. Tte. Gral. Ricchieri S/N (B1659AMA), Buenos Aires, Argentina.
Siniawski D; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina; Cardiology Department. Hospital Italiano de Buenos Aires. Tte. Gral. Juan Domingo Perón 4190 (C1199ABB), Buenos Aires, Argentina. Electronic address: .
Masson G; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina; Cardiology Department. Sanatorio Las Lomas. Diego Carman 555 (B1642AKG), San Isidro, Buenos Aires, Argentina.
Lavalle-Cobo A; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina; Cardiology Department. Sanatorio Finochietto. Av. Córdoba 2678 (C1187AAN), Buenos Aires, Argentina.
Molinero G; Council of Epidemiology and Cardiovascular Prevention, Argentine Society of Cardiology, Azcuenaga 980, C1115AAD Buenos Aires, Argentina.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Apr; Vol. 30 (4), pp. 105655. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article; Multicenter Study; Systematic Review
MeSH Terms :
Cholesterol, LDL/*blood
Dyslipidemias/*drug therapy
Hemorrhagic Stroke/*epidemiology
Hypolipidemic Agents/*therapeutic use
Biomarkers/blood ; Down-Regulation ; Dyslipidemias/blood ; Dyslipidemias/epidemiology ; Humans ; Hypolipidemic Agents/adverse effects ; Incidence ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Associations of long-term exposure to ambient nitrogen dioxide with indicators of diabetes and dyslipidemia in China: A nationwide analysis.
Autorzy :
Zhang Q; School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China.
Liu C; School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China.
Wang Y; Institute of Social Surveys, Peking University, Beijing, China.
Gong J; Institute of Social Surveys, Peking University, Beijing, China.
Wang G; Institute of Social Surveys, Peking University, Beijing, China.
Ge W; Regeneron Pharmaceuticals Inc., New York, 10591, USA.
Chen R; School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China; Shanghai Typhoon Institute/CMA, Shanghai Key Laboratory of Meteorology and Health, Shanghai, 200030, China. Electronic address: .
Meng X; School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China; Shanghai Typhoon Institute/CMA, Shanghai Key Laboratory of Meteorology and Health, Shanghai, 200030, China. Electronic address: .
Zhao Y; National School of Development, Peking University, Beijing, China.
Kan H; School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China.
Pokaż więcej
Źródło :
Chemosphere [Chemosphere] 2021 Apr; Vol. 269, pp. 128724. Date of Electronic Publication: 2020 Oct 24.
Typ publikacji :
Journal Article
MeSH Terms :
Air Pollutants*/adverse effects
Air Pollutants*/analysis
Air Pollution*/adverse effects
Air Pollution*/analysis
Diabetes Mellitus*/chemically induced
Diabetes Mellitus*/epidemiology
Dyslipidemias*/chemically induced
Dyslipidemias*/epidemiology
China/epidemiology ; Cross-Sectional Studies ; Environmental Exposure/adverse effects ; Environmental Exposure/analysis ; Humans ; Longitudinal Studies ; Nitrogen Dioxide/analysis ; Particulate Matter/analysis
Czasopismo naukowe
Tytuł :
The efficacy of niacin supplementation in type 2 diabetes patients: Study protocol of a randomized controlled trial.
Autorzy :
Yan X; Department of General Practice, The Second Affiliated Hospital of Dalian Medical University, Liaoning, China.
Wang S
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Mar 26; Vol. 100 (12), pp. e22272.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2/*complications
Dietary Supplements/*adverse effects
Dyslipidemias/*diet therapy
Niacin/*administration & dosage
Adult ; Delayed-Action Preparations/administration & dosage ; Delayed-Action Preparations/adverse effects ; Diabetes Mellitus, Type 2/blood ; Double-Blind Method ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/etiology ; Female ; Glycated Hemoglobin A/analysis ; Humans ; Lipids/blood ; Male ; Middle Aged ; Niacin/adverse effects ; Prospective Studies ; Randomized Controlled Trials as Topic ; Self Report/statistics & numerical data ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Chronic treatment with anti-GIPR mAb alone and combined with DPP-4 inhibitor correct obesity, dyslipidemia and nephropathy in rodent animals.
Autorzy :
Chen J; Hangzhou Red Cross Hospital, Xiacheng District, Hangzhou City 310003, Zhejiang Province, PR China. Electronic address: .
Zheng S; Hangzhou Red Cross Hospital, Xiacheng District, Hangzhou City 310003, Zhejiang Province, PR China.
Hu Y; Hangzhou Red Cross Hospital, Xiacheng District, Hangzhou City 310003, Zhejiang Province, PR China.
Mou X; Hangzhou Red Cross Hospital, Xiacheng District, Hangzhou City 310003, Zhejiang Province, PR China.
Wang H; The Second Clinical Medical College, Zhejiang Chinese Medical University, Binjiang District, Hangzhou City 310051, Zhejiang Province, PR China.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Mar 15; Vol. 269, pp. 119038. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal/*pharmacology
Dipeptidyl Peptidase 4/*chemistry
Dipeptidyl-Peptidase IV Inhibitors/*pharmacology
Dyslipidemias/*drug therapy
Kidney Diseases/*drug therapy
Obesity/*drug therapy
Receptors, Gastrointestinal Hormone/*antagonists & inhibitors
Animals ; Body Weight ; Diet, High-Fat/adverse effects ; Drug Therapy, Combination ; Dyslipidemias/etiology ; Dyslipidemias/pathology ; Kidney Diseases/etiology ; Kidney Diseases/pathology ; Male ; Mice ; Mice, Knockout ; Mice, Obese ; Obesity/etiology ; Obesity/pathology ; Receptors, Gastrointestinal Hormone/immunology ; Receptors, Gastrointestinal Hormone/physiology ; Weight Loss
Czasopismo naukowe
Tytuł :
Lipid profiles and the risk of new-onset hypertension in a Chinese community-based cohort.
Autorzy :
He D; Department of Cardiology, Peking University First Hospital, Beijing, China.
Fan F; Department of Cardiology, Peking University First Hospital, Beijing, China. Electronic address: .
Jia J; Department of Cardiology, Peking University First Hospital, Beijing, China.
Jiang Y; Department of Cardiology, Peking University First Hospital, Beijing, China.
Sun P; Department of Cardiology, Peking University First Hospital, Beijing, China.
Wu Z; Department of Cardiology, Peking University First Hospital, Beijing, China.
Li J; Department of Cardiology, Peking University First Hospital, Beijing, China.
Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China.
Zhang Y; Department of Cardiology, Peking University First Hospital, Beijing, China. Electronic address: .
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Mar 10; Vol. 31 (3), pp. 911-920. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Pressure*
Dyslipidemias/*blood
Hypertension/*epidemiology
Lipids/*blood
Beijing/epidemiology ; Biomarkers/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Female ; Humans ; Hypertension/diagnosis ; Hypertension/physiopathology ; Incidence ; Male ; Middle Aged ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
A new player in the fight against dyslipidemia - bempedoic acid.
Autorzy :
Blödt K; Kardiologie/Angiologie, Klinik für Innere Medizin II, Universitätsklinikum Ulm, Germany.
Pokaż więcej
Źródło :
VASA. Zeitschrift fur Gefasskrankheiten [Vasa] 2021 Feb; Vol. 50 (2), pp. 159.
Typ publikacji :
Journal Article
MeSH Terms :
Dicarboxylic Acids*
Dyslipidemias*/diagnosis
Dyslipidemias*/drug therapy
Dyslipidemias*/epidemiology
Fatty Acids ; Humans
Czasopismo naukowe
Tytuł :
Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
Autorzy :
Farnier M; PEC2, EA 7460, University of Bourgogne Franche-Comté, 21000 Dijon, France; Cardiology Department, University Hospital Centre of Dijon Bourgogne, 21000 Dijon, France. Electronic address: .
Zeller M; PEC2, EA 7460, University of Bourgogne Franche-Comté, 21000 Dijon, France; Cardiology Department, University Hospital Centre of Dijon Bourgogne, 21000 Dijon, France.
Masson D; Inserm, LNC UMR 1231, FCS Bourgogne Franche-Comté, LipSTIC LabEx, 21078 Dijon, France.
Cottin Y; PEC2, EA 7460, University of Bourgogne Franche-Comté, 21000 Dijon, France; Cardiology Department, University Hospital Centre of Dijon Bourgogne, 21000 Dijon, France.
Pokaż więcej
Źródło :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2021 Feb; Vol. 114 (2), pp. 132-139. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Atherosclerosis/*blood
Dyslipidemias/*blood
Triglycerides/*blood
Animals ; Atherosclerosis/diagnosis ; Atherosclerosis/epidemiology ; Atherosclerosis/prevention & control ; Biomarkers/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/epidemiology ; Dyslipidemias/therapy ; Heart Disease Risk Factors ; Humans ; Hypolipidemic Agents/therapeutic use ; Prognosis ; Risk Assessment ; Risk Reduction Behavior
Czasopismo naukowe
Tytuł :
Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
Autorzy :
Desjobert E; Department of cardiology, hôpital européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Université de Paris, 75006 Paris, France.
Tea V; Department of cardiology, hôpital européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Université de Paris, 75006 Paris, France.
Schiele F; Department of cardiology, university hospital Jean-Minjoz, 25000 Besançon, France.
Ferrières J; Department of cardiology, Rangueil hospital, 31400 Toulouse, France.
Simon T; Department of clinical pharmacology and unité de recherche clinique (URC-Est), hôpital Saint-Antoine, AP-HP, 75012 Paris, France; Université Pierre-et-Marie-Curie (UPMC-Paris 06), 75005 Paris, France.
Danchin N; Department of cardiology, hôpital européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Université de Paris, 75006 Paris, France.
Puymirat E; Department of cardiology, hôpital européen Georges-Pompidou (HEGP), AP-HP, 75015 Paris, France; Université de Paris, 75006 Paris, France. Electronic address: .
Pokaż więcej
Corporate Authors :
FAST-MI investigators
Źródło :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2021 Feb; Vol. 114 (2), pp. 88-95. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Secondary Prevention*
Dyslipidemias/*drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Lipids/*blood
Non-ST Elevated Myocardial Infarction/*therapy
ST Elevation Myocardial Infarction/*therapy
Aged ; Aged, 80 and over ; Biomarkers/blood ; Drug Utilization ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/mortality ; Female ; France ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/diagnosis ; Non-ST Elevated Myocardial Infarction/mortality ; Patient Discharge ; Practice Patterns, Physicians' ; Recurrence ; Registries ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnosis ; ST Elevation Myocardial Infarction/mortality ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
Autorzy :
Julián MT; Department of Endocrinology and Nutrition, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
Pera G; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.
Soldevila B; Department of Endocrinology and Nutrition, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Caballería L; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.
Julve J; Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Puig-Jové C; Department of Endocrinology and Nutrition, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
Morillas R; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.; Hepatology Department, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
Torán P; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.
Expósito C; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Spain.; Centro d'Investigaciones Biomédicas en Red, Enfermedades Hepatologia y Digestivas, Barcelona, Spain.
Puig-Domingo M; Department of Endocrinology and Nutrition, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Castelblanco E; Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Franch-Nadal J; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Primary Health Care Center Raval Sud, Gerència d'Atenció Primaria, Institut Català de la Salut, Barcelona, Spain.
Cusi K; Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA.
Mauricio D; Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.; Faculty of Medicine, University of Vic, Central University of Catalonia, Vic, Spain.
Alonso N; Department of Endocrinology and Nutrition, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło :
European journal of endocrinology [Eur J Endocrinol] 2021 Apr; Vol. 184 (4), pp. 587-596.
Typ publikacji :
Journal Article
MeSH Terms :
Atherosclerosis/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Dyslipidemias/*epidemiology
Hyperglycemia/*epidemiology
Liver Cirrhosis/*epidemiology
Non-alcoholic Fatty Liver Disease/*epidemiology
Adolescent ; Adult ; Aged ; Atherosclerosis/etiology ; Comorbidity ; Diabetes Mellitus, Type 2/complications ; Dyslipidemias/complications ; Elasticity Imaging Techniques ; Female ; Humans ; Hyperglycemia/complications ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease/complications ; Prevalence ; Risk Factors ; Severity of Illness Index ; Spain/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Advances in biological therapies for dyslipidemias and atherosclerosis.
Autorzy :
Valanti EK; 4th Department of Internal Medicine, Clinical Genomics and Pharmacogenomics Unit, 'Attikon' Hospital, Medical School, National and Kapodistrian University of Athens, Greece; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Greece; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dalakoura-Karagkouni K; Laboratory of Biochemistry, University of Crete Medical School Heraklion, Greece.
Siasos G; First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Kardassis D; Laboratory of Biochemistry, University of Crete Medical School Heraklion, Greece; Division of Gene Regulation and Genomics, Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology of Hellas, Heraklion, Greece.
Eliopoulos AG; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Greece; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Department of Biology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Sanoudou D; 4th Department of Internal Medicine, Clinical Genomics and Pharmacogenomics Unit, 'Attikon' Hospital, Medical School, National and Kapodistrian University of Athens, Greece; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Greece; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: .
Pokaż więcej
Źródło :
Metabolism: clinical and experimental [Metabolism] 2021 Mar; Vol. 116, pp. 154461. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Atherosclerosis/*therapy
Biological Therapy/*trends
Dyslipidemias/*therapy
Animals ; Atherosclerosis/epidemiology ; Biological Therapy/methods ; Dyslipidemias/epidemiology ; Endocrinology/methods ; Endocrinology/trends ; Humans ; Therapies, Investigational/methods ; Therapies, Investigational/trends
Czasopismo naukowe
Tytuł :
Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years.
Autorzy :
Kaneko H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan; The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan. Electronic address: .
Itoh H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Kiriyama H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Kamon T; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Fujiu K; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan; The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan.
Morita K; The Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan; The Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Michihata N; The Department of Health Services Research, The University of Tokyo, Tokyo, Japan.
Jo T; The Department of Health Services Research, The University of Tokyo, Tokyo, Japan.
Takeda N; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Morita H; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Yasunaga H; The Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Komuro I; The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2021 Mar 01; Vol. 142, pp. 59-65. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Angina Pectoris/*epidemiology
Dyslipidemias/*epidemiology
Heart Failure/*epidemiology
Myocardial Infarction/*epidemiology
Stroke/*epidemiology
Adult ; Angina Pectoris/blood ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/epidemiology ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Dyslipidemias/blood ; Female ; Heart Failure/blood ; Humans ; Japan/epidemiology ; Longitudinal Studies ; Male ; Middle Aged ; Multivariate Analysis ; Myocardial Infarction/blood ; Proportional Hazards Models ; Risk Factors ; Stroke/blood ; Triglycerides/blood ; Young Adult
Czasopismo naukowe
Tytuł :
Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.
Autorzy :
Berger JH; Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: .
Chen F; Healthcare Analytics Unit, The Children's Hospital of Philadelphia, Philadelphia, PA.
Faerber JA; Healthcare Analytics Unit, The Children's Hospital of Philadelphia, Philadelphia, PA.
O'Byrne ML; Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA; Leonard Davis Institute for Health Economics and Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, PA.
Brothers JA; Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
American heart journal [Am Heart J] 2021 Feb; Vol. 232, pp. 39-46. Date of Electronic Publication: 2020 Oct 24.
Typ publikacji :
Journal Article
MeSH Terms :
Organ Transplantation*
Diabetes Mellitus/*epidemiology
Dyslipidemias/*diagnosis
Guideline Adherence/*statistics & numerical data
Heart Diseases/*epidemiology
Renal Insufficiency, Chronic/*epidemiology
Antineoplastic Agents/therapeutic use ; Autoimmune Diseases/epidemiology ; Child ; Cohort Studies ; Dyslipidemias/epidemiology ; Endocrine System Diseases/epidemiology ; Female ; Humans ; Male ; Mass Screening ; Metabolic Diseases/epidemiology ; Metabolic Syndrome/epidemiology ; Neoplasms/drug therapy ; Neoplasms/epidemiology ; Odds Ratio ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Assessment ; Transplant Recipients
Czasopismo naukowe
Tytuł :
Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial.
Autorzy :
León-Martínez JM; Health Science University Center, Department of Physiology, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico.
Martínez-Abundis E; Health Science University Center, Department of Physiology, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico.
González-Ortiz M; Health Science University Center, Department of Physiology, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico.
Pérez-Rubio KG; Health Science University Center, Department of Physiology, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico.
Pokaż więcej
Źródło :
Journal of medicinal food [J Med Food] 2021 Feb; Vol. 24 (2), pp. 111-115. Date of Electronic Publication: 2020 May 12.
Typ publikacji :
Clinical Trial; Journal Article; Randomized Controlled Trial
MeSH Terms :
Bezafibrate*/administration & dosage
Dyslipidemias*/drug therapy
Berberine/*administration & dosage
Adult ; Humans ; Lipids/blood ; Middle Aged ; Pilot Projects ; Triglycerides/blood
Czasopismo naukowe
Tytuł :
Association between Dyslipidemia and Mercury Exposure in Adults.
Autorzy :
Kang P; College of Nursing, Woosuk University, Wanju 55338, Korea.
Shin HY; National Cancer Control Institute, National Cancer Center, Goyang 10408, Korea.; College of Nursing, Baekseok Culture University, Cheonan 31065, Korea.
Kim KY; Department of Nursing, College of Nursing, Gachon University, Incheon 21936, Korea.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jan 18; Vol. 18 (2). Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dyslipidemias*/chemically induced
Dyslipidemias*/epidemiology
Mercury*/toxicity
Metals, Heavy*
Adult ; Aged ; Female ; Humans ; Male ; Nutrition Surveys ; Republic of Korea/epidemiology ; Risk Factors
Czasopismo naukowe
Tytuł :
Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease.
Autorzy :
Markelić I; University Hospital Centre Zagreb, Clinical Department for Pulmonary Diseases Jordanovac, Zagreb, Croatia.
Hlapčić I; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medical Biochemistry and Haematology, Zagreb, Croatia.
Rogić D; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medical Biochemistry and Haematology, Zagreb, Croatia; University Hospital Centre Zagreb, Clinical Institute of Laboratory Diagnostics, Zagreb, Croatia.
Rako I; University Hospital Centre Zagreb, Clinical Institute of Laboratory Diagnostics, Zagreb, Croatia.
Samaržija M; University Hospital Centre Zagreb, Clinical Department for Pulmonary Diseases Jordanovac, Zagreb, Croatia; University of Zagreb, School of Medicine, Zagreb, Croatia.
Popović-Grle S; University Hospital Centre Zagreb, Clinical Department for Pulmonary Diseases Jordanovac, Zagreb, Croatia; University of Zagreb, School of Medicine, Zagreb, Croatia.
Rumora L; University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medical Biochemistry and Haematology, Zagreb, Croatia.
Vukić Dugac A; University Hospital Centre Zagreb, Clinical Department for Pulmonary Diseases Jordanovac, Zagreb, Croatia; University of Zagreb, School of Medicine, Zagreb, Croatia. Electronic address: .
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Jan 04; Vol. 31 (1), pp. 153-161. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Atherosclerosis/*blood
Dyslipidemias/*blood
Lipids/*blood
Pulmonary Disease, Chronic Obstructive/*blood
Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Atherosclerosis/diagnosis ; Atherosclerosis/epidemiology ; Biomarkers/blood ; Bronchodilator Agents/therapeutic use ; Comorbidity ; Dyslipidemias/diagnosis ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Male ; Middle Aged ; Prognosis ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Smoking/adverse effects ; Smoking/blood
Czasopismo naukowe
Tytuł :
Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.
Autorzy :
Zheng X; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Zhong C; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Zhu Z; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Zhang K; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Peng H; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Xu T; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China; Department of Neurology, Affiliated Hospital of Nantong University, Nantong, China.
Bu X; Department of Epidemiology, School of Public Health, Chongqing Medical University, Chongqing, China.
Che B; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Xu T; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Wang A; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.
Chen J; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Zhang Y; Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China. Electronic address: .
He J; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Jan 04; Vol. 31 (1), pp. 209-215. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Dyslipidemias/*blood
Ischemic Stroke/*blood
Lipids/*blood
Matrix Metalloproteinase 9/*blood
Aged ; Biomarkers/blood ; China/epidemiology ; Disability Evaluation ; Dyslipidemias/diagnosis ; Dyslipidemias/mortality ; Female ; Humans ; Ischemic Stroke/diagnosis ; Ischemic Stroke/mortality ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Time Factors ; Up-Regulation
Czasopismo naukowe
Tytuł :
Lipid levels and the risk of hemorrhagic stroke: A dose-response meta-analysis.
Autorzy :
Jin X; Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China.
Chen H; Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China.
Shi H; Clinical Department One, China Medical University, Shenyang, China.
Fu K; Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China.
Li J; Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China.
Tian L; Department of Geriatrics, Shengjing Hospital, China Medical University, Shenyang, China. Electronic address: .
Teng W; Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China. Electronic address: .
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2021 Jan 04; Vol. 31 (1), pp. 23-35. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Dyslipidemias/*epidemiology
Hemorrhagic Stroke/*epidemiology
Lipids/*blood
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Dyslipidemias/mortality ; Female ; Hemorrhagic Stroke/blood ; Hemorrhagic Stroke/diagnosis ; Hemorrhagic Stroke/mortality ; Humans ; Incidence ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
[Management of dyslipidaemias: The New 2019 ESC/EAS-Guideline].
Autorzy :
Vogt A
Weingärtner O
Pokaż więcej
Transliterated Title :
Therapieempfehlungen bei Fettstoffwechselstörungen: Die neue Leitlinie von 2019.
Źródło :
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2021 Jan; Vol. 146 (2), pp. 75-84. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Dyslipidemias*/complications
Dyslipidemias*/diagnosis
Dyslipidemias*/epidemiology
Dyslipidemias*/therapy
Anticholesteremic Agents/therapeutic use ; Cardiovascular Diseases ; Cholesterol, LDL/blood ; Humans ; Practice Guidelines as Topic ; Risk Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies